Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_assertion type Assertion NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_head.
- NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_assertion wasGeneratedBy ECO_0000203 NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_provenance.
- NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_assertion wasDerivedFrom befree-20140225 NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_provenance.
- NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_assertion SIO_000772 16914580 NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_provenance.
- NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_assertion evidence source_evidence_literature NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_provenance.
- NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_assertion description "[Taken together, these findings suggest that FAK siRNA-DOPC plus docetaxel or platinum might be a novel therapeutic approach against ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610980.RA1Ad_CPSCAABaITOBrX6_OYbOxgMsabRJMKmAEd4ahF8130_provenance.